| Literature DB >> 34946289 |
Aurelija Beigienė1, Daiva Petruševičienė1, Vitalija Barasaitė1, Raimondas Kubilius1, Jūratė Macijauskienė2.
Abstract
Background andEntities:
Keywords: balance training; cardiac rehabilitation; frailty; gait speed; ischemic heart disease; resistance training
Mesh:
Year: 2021 PMID: 34946289 PMCID: PMC8705993 DOI: 10.3390/medicina57121344
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Study flowchart.
Sociodemographic and clinical characteristics of the study population.
| Characteristic | All ( | IG-1 ( | IG-2 ( | CG ( | |
|---|---|---|---|---|---|
| Age, years | 73.1 ± 5.3 | 72.6 ± 4.6 | 70.6 ± 4.3 | 74.6 ± 6.3 | 0.008 |
| Sex, | |||||
| Female | 26 (26.8) | 8 (25) | 11 (33.3) | 7 (21.9) | 0.558 |
| Male | 71 (73.2) | 24 (75) | 22 (66.7) | 25 (78.1) | |
| Height, m | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.234 |
| Weight, kg | 80.1 ± 13.7 | 80.8 ± 12.3 | 83.8 ± 15.8 | 77.8 ± 12.3 | 0.220 |
| Body mass index, kg/m2 | 27.9 ± 3.9 | 28.5 ± 3.4 | 28.4 ± 4.2 | 26.9 ± 4 | 0.176 |
| Current smokers, | 11 (11.3) | 4 (12.5) | 3 (9.1) | 4 (12.5) | 0.882 |
| LV ejection fraction, % | 47.7 ± 5.3 | 48.8 ± 5.1 | 46.8 ± 4.6 | 47.5 ± 56 | 0.311 |
| CR duration, days | 18.9 ± 1.7 | 19.6 ± 0.8 | 18.8 ± 1.6 | 18.3 ± 2.3 | 0.008 |
| Comorbidities, | |||||
| Diabetes | 15 (15.5) | 7 (21.9) | 2 (6.1) | 6 (18.8) | 0.174 |
| Atrial fibrillation | 18 (18.6) | 6 (18.8) | 7 (21.2) | 5 (15.6) | 0.845 |
| Degenerative joint disease | 6 (6.2) | 1 (3.1) | 4 (12.1) | 1 (3.1) | 0.219 |
| Cancer | 8 (8.2) | 3 (9.4) | 3 (9.1) | 2 (6.3) | 0.881 |
| Treatment, | |||||
| Coronary artery by-pass graft | 58 (59.8) | 25 (78.1) | 17 (51.5) | 16 (50) | 0.035 |
| PTCA | 39 (40.2) | 7 (21.9) | 16 (48.5) | 16 (50) | |
| Medication, | |||||
| ACE inhibitor | 78 (80.4) | 22 (68.8) | 27 (81.8) | 29 (90.6) | 0.085 |
| Diuretic | 70 (72.2) | 26 (81.3) | 24 (72.7) | 20 (62.5) | 0.246 |
| Statin | 93 (95.9) | 30 (93.8) | 32 (97) | 31 (96.9) | 0.761 |
Values are mean ± standard deviation unless indicated otherwise. * p value by the chi-square test (for categorical data) or ANOVA (for normally distributed continuous data). Bold p-values indicate statistically significant differences. IG-1, intervention group-1; IG-2, intervention group-2; CG, control group; LV, left ventricular; CR, cardiac rehabilitation; PTCA, percutaneous transluminal coronary angioplasty; ACE, angiotensin-converting enzyme.
Results of the Edmonton Frail Scale.
| Frailty Assessment | All ( | IG-1 ( | IG-2 ( | CG ( | |
|---|---|---|---|---|---|
| Total EFS score (0–17), median (IQR) | 5 (4–6) | 5 (4–6.8) | 5 (3–7) | 5 (4–6) | 0.880 |
| Frailty classification by EFS, | |||||
| Fit (0–3) | 20 (20.6) | 4 (12.5) | 9 (27.3) | 7 (21.9) | 0.643 |
| Vulnerable (4–5) | 41 (42.3) | 16 (50) | 12 (36.4) | 13 (40.6) | |
| Frailty (≥6) | 36 (37.1) | 12 (37.5) | 12 (36.4) | 12 (37.5) | |
| EFS items | |||||
| Cognition, | |||||
| Clock drawing test faultless | 30 (30.9) | 8 (25) | 11 (33.3) | 11 (34.4) | 0.672 |
| Clock drawing test with minor and major errors | 67 (69.1) | 24 (75) | 22 (66.7) | 21 (65.6) | 0.210 |
| One and more hospitalizations in the past year, | 87 (89.7) | 28 (87.5) | 31 (93.9) | 28 (87.5) | 0.902 |
| General health status, | |||||
| Excellent, very good, good | 22 (22.7) | 7 (21.9) | 9 (27.3) | 6 (18.8) | 0.708 |
| Fair, poor | 75 (77.3) | 25 (78.1) | 24 (72.7) | 26 (81.3) | 0.470 |
| Functional independence, | |||||
| Independent | 76 (78.4) | 27 (84.4) | 27 (81.8) | 22 (68.8) | 0.265 |
| Require help in two and more activities | 21 (21.6) | 5 (15.6) | 6 (18.2) | 10 (31.3) | 0.944 |
| Social support, | |||||
| Always | 91 (93.6) | 31 (96.9) | 31 (93.9) | 29 (90.6) | 0.957 |
| Sometimes, never | 6 (6.2) | 1 (3.1) | 2 (6.1) | 3 (9.4) | NA |
| Medication use, | |||||
| Amount ≥ 5 | 80 (82.5) | 27 (84.4) | 28 (84.8) | 25 (78.1) | 0.916 |
| Forgetfulness | 14 (14.4) | 5 (15.6) | 3 (9.1) | 6 (18.8) | NA |
| Nutrition–weight loss, | 22 (22.7) | 8 (25) | 8 (24.2) | 6 (18.8) | 0.808 |
| Mood–sad, depressed, | 30 (30.9) | 11 (34.4) | 10 (30.3) | 9 (28.1) | 0.860 |
| Urinary incontinence, | 7(7.2) | 3 (9.4) | 2 (6.1) | 2 (6.3) | NA |
| Functional performance by the TUG test, | |||||
| 0–10 s | 68 (70.1) | 23 (71.9) | 23 (69.7) | 22 (68.8) | 0.962 |
| 11–20 s | 29 (29.9) | 9 (28.1) | 10 (30.3) | 10 (31.3) | 0.607 |
* p value by the chi-square test (for categorical data). IG-1, intervention group-1; IG-2, intervention group-2; CG, control group; EFS, Edmonton frail scale; TUG, Timed Get Up and Go test; IQR, interquartile range; NA, not applicable.
Gait speed before and after cardiac rehabilitation.
| Parameter | IG-1 ( | IG-2 ( | CG ( | |||||
|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T0 | T1 | T0 | T1 | Within groups | Among groups | |
| Gait speed, m/s | 1.23 (1.02–1.45) | 1.41 (1.18–1.61) | 1.37 (0.92–1.59) | 1.56 (1.3–1.66) | 1.35 (0.94–1.56) | 1.53 (1–1.68) | <0.05 | 0.100 |
Values are medians (interquartile range). * p-value by Kruskal–Wallis test. IG-1, intervention group-1; IG-2, intervention group-2; CG, control group.